Purchase Order 75D30122P14880
- Not listed
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, with a potential value of $159,999.10. The contract has a completion date of September 14, 2023 and was awarded on September 15, 2022. Illumina has previously received federal contract awards from agencies such as the NIH, USDA, and VA to provide a range of sequencing systems, reagents, and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $144,302.41 contract provides supplies - chemicals to support the agency's research and diagnostics needs. This award does not have a set-aside designation. Illumina has previously been awarded prime federal contracts by agencies such as NIH, USDA,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $54,367.08 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the repair/replacement and advanced support plan for ISEQ equipment, with performance to be completed by August 20, 2028. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and...
- This is a $101,594.39 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has an existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs, and has received prior federal contract...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $79,283.85 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to supply...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $20,634.75 contract is for the provision of ILLUMINA REAGENTS to support the agency's research and diagnostic activities. Illumina has a history of providing sequencing systems, consumables, and services to federal agencies like the NIH, USDA, and VA....
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $229,055.19 contract is for the delivery of laboratory supplies, with no set-aside used. Illumina has previously received prime federal contracts from agencies like the National Institutes of Health, USDA, VA, and others to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $107,368.22 firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of WDPB ILLUMINA LAB SUPPLIES, to be delivered by September 30, 2022. Illumina has a history of providing sequencing systems, reagents, and other supporting products and services to various federal agencies, including the National Institutes of Health (NIH), Department of Agriculture (USDA), and Department of Veterans Affairs (VA). This award does not appear to have any set-aside designation. Additionally, Illumina holds an Indefinite Delivery Contract worth up to $3.3 million with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs at the Naval Medical Research Center.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 8/17/22 | |
| Not listed | Not listed | $107.4k | 8/11/22 |